|
|
Volumn 20, Issue 10, 2002, Pages 962-963
|
|
Setbacks for blood substitute companies
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD SUBSTITUTE;
ARTICLE;
BIOTECHNOLOGY;
CANADA;
DRUG APPROVAL;
ECONOMIC ASPECT;
ECONOMICS;
UNITED STATES;
BIOTECHNOLOGY;
BLOOD SUBSTITUTES;
CANADA;
DRUG APPROVAL;
ECONOMIC COMPETITION;
UNITED STATES;
|
|
EID: 0036780008
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1002-962 Document Type: Note |
|
Times cited : (18)
|
|
References (0)
|
